Genpharmasec Limited has received a routine compliance certificate from its share transfer agent for the quarter ended December 31, 2025. The certificate confirms established procedures for handling physical share conversions to electronic form. For this period, the company reported that no physical share certificates were received for dematerialization. This update assures shareholders of ongoing compliance in maintaining accurate and efficient share records, even with no conversion activity this quarter.